SUCCESSFUL TREATMENT BY RITUXIMAB OF RHEUMATOID ARTHRITIS RESISTANT TO THE STANDARD SCHEME OF BASIC THERAPY
- Authors: Kiyakbaev GG1, Fomin VV1, Lebedeva MV1, Pullin AA1, Kiyakbaev G.G.1, Fomin V.V.1, Lebedeva M.V.1, Pulin A.A.1
-
Affiliations:
- Issue: No 13 (2010)
- Pages: 77-80
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278546
- ID: 278546
Cite item
Full Text
Abstract
About the authors
G G Kiyakbaev
V V Fomin
M V Lebedeva
A A Pullin
Gayrat Gayratovich Kiyakbaev
Viktor Viktorovich Fomin
Marina Valer'evna Lebedeva
Andrey Alekseevich Pulin
References
- Насонов Е.Л. Ритуксимаб в лечении ревматических болезней // Научно-практическая ревматология. 2008. Прил. к № 1. С. 3-10.
- Каратеев Д.Е. Современная медикаментозная терапия ревматоидного артрита // Лечащий врач. 2007. № 2.
- Клинические рекомендации. Ревматология // Под ред. Е.Л. Насонова. М., 2006. 288 с.
- Emery P, Suarez-Almazor M. Rheumatoid Arthritis. Clin Evid 2003;10:1454-76.
- Салихов И.Г., Мясоутова Л.И., Бадеева М.Ю. и др. Опыт применения ритуксимаба в лечении ревматоидного артрита // Лечащий врач. 2008. № 4. С. 88-90.
- Cohen SB, Emery P, Greenwald MW, et al; REFLEX Trial Group. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54(9):2793-806.
- Emery P, Fleishmann R, Filipowicz-Sosnowska A, et al. for the DANCER Study group. The Efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment. Results of a phase IIb randomized, double-blind, placebo-controlled dose-range trial. Arth Rneum 2006;54:1390-400.
- Emery Р, Rigby WF, Combe B, et al. Efficacy and Safety of Rituximab (RTX) as first-line biologic therapy in patients with active rheumatoid arthritis: results of a phase III randomized controlled study (SERENA). and ACR 2008, San Francisco, abstr. 364.
- Каратеев Д.Е., Лучихина Е.Л., Тогизбаев Г. Современные принципы ведения больных ранним артритом // РМЖ. 2008. № 24. С. 1610.
- Rivera A, Chen CC, Ron N, et al. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int Immunol 2001;13:1583-93. doi: 10.1093/intimm/13.12.1583.
- Finckh A, Ciurea A, Brulhart L, et al. B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis Rheum 2007;56:1417-23.